질 회춘 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 치료 유형별, 지역별 및 경쟁(2021-2031년)

The Global Vaginal Rejuvenation Market is projected to expand from USD 3.37 Billion in 2025 to USD 6.72 Billion by 2031, reflecting a compound annual growth rate of 12.19%. This market encompasses a range of surgical and non-surgical interventions aimed at improving the aesthetic appeal or restoring the physiological function of female genitalia. Common procedures include reconstructive surgeries like vaginoplasty and labiaplasty, as well as minimally invasive treatments that employ radiofrequency or laser technologies to treat tissue laxity. Growth in this sector is largely fueled by heightened awareness regarding female sexual wellness, the reducing stigma around genital aesthetic improvements, and increasing demand from women addressing age-related or postpartum physiological changes, supported by technologies that shorten recovery times.

However, the market faces significant hurdles due to strict regulatory oversight concerning the safety and effectiveness of energy-based devices. Health authorities frequently enforce rigorous guidelines that can postpone product approvals and restrict the uptake of non-surgical alternatives over safety worries. Despite these regulatory obstacles, established markets exhibit continued strength and expansion. As reported by the American Society of Plastic Surgeons, 10,827 labiaplasty surgeries were conducted in the United States in 2024, underlining the persistent consumer interest in these specialized medical interventions.

Market Driver

Technological innovations in minimally invasive energy-based therapies are transforming the global vaginal rejuvenation landscape by providing efficient, non-surgical substitutes for conventional operations. The evolution of advanced laser and radiofrequency systems has broadened the target demographic to include women desiring functional enhancements without the risks and recovery time linked to surgery. This transition is highlighted by the strong financial results of major industry participants specializing in these modern platforms; for instance, InMode Ltd. reported total annual revenues of $394.8 million in their 'Fourth Quarter and Full Year 2024 Financial Results' released in February 2025, demonstrating substantial adoption of their technologies. Furthermore, patient satisfaction remains high, with RealSelf reporting a 95% "Worth It" rating for vaginoplasty in 2024 based on consumer reviews, indicating robust confidence in these treatments.

Additionally, the rising prevalence of Stress Urinary Incontinence (SUI) among women acts as a vital clinical catalyst, boosting demand for both non-surgical and surgical vaginal rejuvenation options. As populations age and lifestyles change, the incidence of pelvic floor dysfunction increases, creating a need for therapeutic solutions that address both aesthetic concerns and functional rehabilitation. A study cited by the International Continence Society in 'ICS 2024 Abstract 694' from October 2024 found that 49.4% of professional women in healthcare suffered from involuntary urine loss, underscoring how widespread this condition is even among active working demographics. This significant prevalence drives the urgent requirement for accessible treatments, ensuring the market expands beyond purely cosmetic uses to tackle fundamental women's health challenges.

Market Challenge

Rigorous regulatory oversight concerning the efficacy and safety of energy-based medical devices represents a significant obstacle to the growth of the global vaginal rejuvenation industry. Health authorities often mandate strict evaluation protocols for radiofrequency and laser technologies, which are fundamental to the non-surgical sector of this market. These stringent guidelines frequently lead to extended approval periods and limited marketing authorizations, generating considerable uncertainty for device manufacturers and restricting the accessibility of minimally invasive treatment choices.

This regulatory climate directly impedes market progression by retarding the uptake of emerging technologies that offer shorter recovery times, a primary attraction for modern consumers. The effect of these restrictions is especially severe considering the demographic composition of patients, who depend heavily on safe aesthetic enhancements. According to the International Society of Aesthetic Plastic Surgery (ISAPS), it was reported in 2025 that 48.4% of all external genital surgeries were conducted on individuals aged 18 to 34. This high concentration of younger patients highlights the market's sensitivity, as regulatory safety alerts or postponed product introductions can rapidly erode consumer trust and dampen demand within this critical age segment.

Market Trends

The normalization of intimate wellness through digital marketing is actively transforming the sector from a niche medical topic into a rapidly growing consumer lifestyle segment. This evolution is driven by a significant increase in venture capital flowing into "FemTech" enterprises, which leverage direct-to-consumer channels to destigmatize discussions regarding genital aesthetics and sexual health. This increased visibility is drawing a wider range of women who perceive these procedures as vital self-care rather than strictly medical requirements; validating this trend, Silicon Valley Bank's 'Innovation in Women's Health Report' from April 2025 noted that global investment in women's health firms hit a record $2.6 billion in 2024. This capital infusion enables companies to launch advanced educational initiatives that bypass conventional intermediaries, effectively broadening the market for both clinical treatments and home-use devices.

Concurrently, the increasing appeal of combined "Mommy Makeover" packages supports the demand for surgical interventions by grouping genital procedures with extensive body contouring operations. Patients are increasingly seeking comprehensive postpartum restoration, choosing to pair vaginoplasty or labiaplasty with abdominal and breast surgeries to optimize aesthetic results while merging recovery times. This bundling approach is essential for sustaining surgical numbers even as non-invasive alternatives become more common. As per the British Association of Aesthetic Plastic Surgeons (BAAPS) 'Annual Audit Results' in May 2025, abdominoplasty procedures-often combined with vaginal rejuvenation in these protocols-saw a 6% rise in 2024. The continued popularity of these core body surgeries directly reinforces the vaginal rejuvenation market, as surgeons utilize the primary procedure to promote additional genital corrections.

Key Market Players

• Alma Lasers Ltd
• Lutronic Corp.
• ThermiGen, LLC
• vConfidence Inc.
• BTL Indusries Inc.
• Venus Concept Inc.
• Fotona Holdings LLC
• Almirall SA
• Hologic Inc.

Report Scope

In this report, the Global Vaginal Rejuvenation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vaginal Rejuvenation Market, By Treatment Type

• Reconstructive Vaginal Rejuvenation
• Cosmetic Vaginal Rejuvenation

Vaginal Rejuvenation Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vaginal Rejuvenation Market.

Available Customizations:

Global Vaginal Rejuvenation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Vaginal Rejuvenation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Treatment Type (Reconstructive Vaginal Rejuvenation, Cosmetic Vaginal Rejuvenation)
  • 5.2.2. By Region
  • 5.2.3. By Company (2025)
• 5.3. Market Map

6. North America Vaginal Rejuvenation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Treatment Type
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Vaginal Rejuvenation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Treatment Type
  • 6.3.2. Canada Vaginal Rejuvenation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Treatment Type
  • 6.3.3. Mexico Vaginal Rejuvenation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Treatment Type

7. Europe Vaginal Rejuvenation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Treatment Type
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Vaginal Rejuvenation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Treatment Type
  • 7.3.2. France Vaginal Rejuvenation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Treatment Type
  • 7.3.3. United Kingdom Vaginal Rejuvenation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Treatment Type
  • 7.3.4. Italy Vaginal Rejuvenation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Treatment Type
  • 7.3.5. Spain Vaginal Rejuvenation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Treatment Type

8. Asia Pacific Vaginal Rejuvenation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Treatment Type
  • 8.2.2. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Vaginal Rejuvenation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Treatment Type
  • 8.3.2. India Vaginal Rejuvenation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Treatment Type
  • 8.3.3. Japan Vaginal Rejuvenation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Treatment Type
  • 8.3.4. South Korea Vaginal Rejuvenation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Treatment Type
  • 8.3.5. Australia Vaginal Rejuvenation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Treatment Type

9. Middle East & Africa Vaginal Rejuvenation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Treatment Type
  • 9.2.2. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Vaginal Rejuvenation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Treatment Type
  • 9.3.2. UAE Vaginal Rejuvenation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Treatment Type
  • 9.3.3. South Africa Vaginal Rejuvenation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Treatment Type

10. South America Vaginal Rejuvenation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Treatment Type
  • 10.2.2. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Vaginal Rejuvenation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Treatment Type
  • 10.3.2. Colombia Vaginal Rejuvenation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Treatment Type
  • 10.3.3. Argentina Vaginal Rejuvenation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Treatment Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Vaginal Rejuvenation Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Alma Lasers Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Lutronic Corp.
• 15.3. ThermiGen, LLC
• 15.4. vConfidence Inc.
• 15.5. BTL Indusries Inc.
• 15.6. Venus Concept Inc.
• 15.7. Fotona Holdings LLC
• 15.8. Almirall SA
• 15.9. Hologic Inc.

16. Strategic Recommendations

17. About Us & Disclaimer